TOPLINE: A probiotic with good rationale from animal and human studies known as L reuteri (Limosilactobacillus reuteri 6475) failed in a placebo-controlled clinical trial to prevent […]

TOPLINE: Nearly one-fifth of people in Sweden during 2015-2019 had diabetic retinopathy (DR) at the time of type 2 diabetes (T2D) diagnosis, indicating longstanding hyperglycaemia and […]

TOPLINE: In adults with type 1 diabetes (T1D), both management- and emotion-focused virtual group programs can lead to a clinically meaningful reduction in diabetes distress (DD) […]

TOPLINE: In patients with irritable bowel syndrome (IBS), a dietitian-guided 12-week strict low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD) improves quality of life […]

TOPLINE: ChatGPT4 outperformed gastroenterology practitioners and showed better concordance with the 2020 US Multi-Society Task Force on Colorectal Cancer (USMSTF) guidelines in determining rescreening and surveillance […]

TOPLINE: The artificial intelligence (AI) chatbot ChatGPT can significantly improve the readability of online cancer-related patient information while maintaining the content’s quality, a recent study found. […]

TOPLINE: Ionized hypocalcemia is seen in at least one in six pediatric patients with major trauma admitted to the emergency department (ED). METHODOLOGY:  Researchers performed a […]

TOPLINE: In pediatric patients with sepsis presenting to the emergency department (ED), administering antibiotics 330 minutes or later increases the risk for mortality by over three […]

TOPLINE: A clinically significant association exists between fructose and fructan malabsorption in certain patients with irritable bowel syndrome (IBS), indicating that some may benefit from eliminating […]